These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 9850743
21. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide. Tatsuno I, Gottschall PE, Arimura A. Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859 [Abstract] [Full Text] [Related]
24. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. Krane JF, Murphy DP, Carter DM, Krueger JG. J Invest Dermatol; 1991 Apr; 96(4):419-24. PubMed ID: 1848876 [Abstract] [Full Text] [Related]
25. Vasoactive intestinal peptide induces proliferation of human hepatocytes. Khedr MEMS, Abdelmotelb AM, Bedwell TA, Shtaya A, Alzoubi MN, Abu Hilal M, Khakoo SI. Cell Prolif; 2018 Oct; 51(5):e12482. PubMed ID: 30028555 [Abstract] [Full Text] [Related]
26. Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Piazza GA, Ritter JL, Baracka CA. Exp Cell Res; 1995 Jan; 216(1):51-64. PubMed ID: 7813633 [Abstract] [Full Text] [Related]
27. Mutual antagonistic interactions between the thyrotropin (adenosine 3',5'-monophosphate) and protein kinase C/epidermal growth factor (tyrosine kinase) pathways in cell proliferation and differentiation of cultured human thyroid follicles. Kraiem Z, Sadeh O, Yosef M, Aharon A. Endocrinology; 1995 Feb; 136(2):585-90. PubMed ID: 7835292 [Abstract] [Full Text] [Related]
28. Gs and Gq/11 couple vasoactive intestinal peptide and cholinergic stimulation to lacrimal secretion. Meneray MA, Fields TY, Bennett DJ. Invest Ophthalmol Vis Sci; 1997 May; 38(6):1261-70. PubMed ID: 9152245 [Abstract] [Full Text] [Related]
29. The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers. Dvir A, Milner Y, Chomsky O, Gilon C, Gazit A, Levitzki A. J Cell Biol; 1991 May; 113(4):857-65. PubMed ID: 1709168 [Abstract] [Full Text] [Related]
30. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK. Cancer Res; 1992 Jul 01; 52(13):3636-41. PubMed ID: 1617636 [Abstract] [Full Text] [Related]
31. Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors. Kimura M, Inoue H, Hirabayashi K, Natsume H, Ogihara M. Eur J Pharmacol; 2001 Nov 16; 431(2):151-61. PubMed ID: 11728421 [Abstract] [Full Text] [Related]
32. Insulin potentiates mitogenic effect of epidermal growth factor on cultured guinea pig gastric mucous cells. Ogihara S, Yamada M, Saito T, Shono M, Rokutan K. Am J Physiol; 1996 Jul 16; 271(1 Pt 1):G104-12. PubMed ID: 8760113 [Abstract] [Full Text] [Related]
33. Comitogenic effects of vasoactive intestinal polypeptide on rat hepatocytes. Kar S, Hasegawa K, Carr BI. J Cell Physiol; 1996 Jul 16; 168(1):141-6. PubMed ID: 8647908 [Abstract] [Full Text] [Related]
34. Tri-iodothyronine induces proliferation in cultured bovine thyroid cells: evidence for the involvement of epidermal growth factor-associated tyrosine kinase activity. Di Fulvio M, Coleoni AH, Pellizas CG, Masini-Repiso AM. J Endocrinol; 2000 Jul 16; 166(1):173-82. PubMed ID: 10856896 [Abstract] [Full Text] [Related]
36. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase. Gründker C, Völker P, Emons G. Endocrinology; 2001 Jun 16; 142(6):2369-80. PubMed ID: 11356684 [Abstract] [Full Text] [Related]
37. Vasoactive intestinal polypeptide and acetylcholine stimulate exocrine secretion of epidermal growth factor from the rat submandibular gland. Skov Olsen P, Kirkegaard P, Poulsen SS, Nexø E. Regul Pept; 1986 Aug 16; 15(1):37-46. PubMed ID: 3489957 [Abstract] [Full Text] [Related]
38. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor. Goursaud S, Pineau N, Becq-Giraudon L, Gressens P, Muller JM, Janet T. J Neuroimmunol; 2005 Jan 16; 158(1-2):94-105. PubMed ID: 15589042 [Abstract] [Full Text] [Related]
39. Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation. Vacas E, Fernández-Martínez AB, Bajo AM, Sánchez-Chapado M, Schally AV, Prieto JC, Carmena MJ. Biochim Biophys Acta; 2012 Oct 16; 1823(10):1676-85. PubMed ID: 22728770 [Abstract] [Full Text] [Related]